title icon
Explore Luminary’s pipeline

Cancer research doesn’t sit still. Neither does our research.

Our product pipeline focuses on underserved cancers and autoimmune disorders. We are aggressively pursuing our BAFF CAR-T and Universal Receptor therapies, both utilizing Allogeneic manufacturing platforms. Here is where we stand today.

Program Type Indication Research & Preclinical Development Phase 1&2 Pivotal
LMY-920 BAFF CAR-T Autologous B-cell Malignancies
Autologous-MCL
LMY-921 BAFF CAR-T Allogeneic B-cell Malignancies
Allogeneic-MCL
LMY-922 BAFF CAR-T Allogeneic Autoimmune Disorders
Scleroderma
LMY-232
Multiple Targets
NORTHSTAR Universal Receptor Solid Tumors
TBD